The JP Morgan country risk indicator has accumulated a rise of over 40 points in a challenging context for emerging countries, affecting the Argentine financial market. This occurs in a scenario of market concern ahead of the presidential elections.
Country risk in Argentina has escalated in the first weeks of the month, with a rise of over 40 points, according to the indicator developed by JP Morgan. This increase occurs in a challenging context for emerging countries and generates concern in the financial market.
The rise in country risk in Argentina is due to economic and political factors that affect investor confidence in the financial market. Market concern ahead of the presidential elections also plays an important role in this increase.
Market operators in Argentina are paying attention to the movements of the country risk indicator, as this can influence the quotation of currencies and financial assets. The rise in country risk can make investors more cautious and reduce their exposure to the Argentine market.
Among the causes of country risk in Argentina are economic factors such as inflation, fiscal deficit, and public debt, which can affect the stability of the financial market. Additionally, the political uncertainty generated by the presidential elections also contributes to the rise in country risk.
JP Morgan has pointed out that the challenging context for emerging countries is also affecting the Argentine financial market. The rise in country risk can have a negative impact on the Argentine economy, leading to a reduction in economic activity and an increase in unemployment.
In the next 30 days, it is likely that the Argentine financial market will remain volatile, with sharp movements in the quotation of currencies and financial assets. Investors should be attentive to changes in the country risk indicator and adjust their investment strategies accordingly.
El Banco Central permite que las financieras usen hasta el 15 % de sus depósitos en dólares para otorgar préstamos a empresas, una medida que busca reactivar la inversión productiva.
La acción de Moderna subió 95 % después de que su vacuna de ARN mensajero contra el cáncer, desarrollada con Merck, obtuviera el primer resultado positivo en una fase 3.
El pronóstico más audaz de Wall Street sitúa al S&P 500 en 9.000 para fin de 2027, un 17 % por encima del nivel actual.
